Emcure Pharmaceuticals Limited (NSE:EMCURE)
India
· Delayed Price · Currency is INR 1,361.40
-14.50 (-1.05%)
At close: Jun 13, 2025, 3:30 PM IST
Emcure Pharmaceuticals Revenue
In the fiscal year ending March 31, 2025, Emcure Pharmaceuticals had annual revenue of 78.96B INR with 18.59% growth. Emcure Pharmaceuticals had revenue of 21.16B in the quarter ending March 31, 2025, with 19.47% growth.
Revenue
78.96B
Revenue Growth
+18.59%
P/S Ratio
3.27
Revenue / Employee
7.28M
Employees
10,852
Market Cap
258.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 78.96B | 12.38B | 18.59% |
| Mar 31, 2024 | 66.58B | 6.72B | 11.23% |
| Mar 31, 2023 | 59.86B | 1.30B | 2.23% |
| Mar 31, 2022 | 58.55B | 8.22B | 16.33% |
| Mar 31, 2021 | 50.33B | -150.80M | -0.30% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2012 | Pro | Pro | Pro |
| Mar 31, 2011 | Pro | Pro | Pro |
| Mar 31, 2010 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 271.45B |
| Apollo Hospitals Enterprise | 217.94B |
| Mankind Pharma | 122.07B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Alkem Laboratories | 129.65B |